Economist Impact: World Cancer Series Europe
On 20 September, the Belgian delegation of the DiCE Team attended the Economist Impact’s World Cancer Series: Europe in Brussels, proudly sup...
Do You Dare to Think Differently about Cancer?
The Cancer Grand Challenges mission is “Uniting the World’s brightest minds against cancer’s toughest challenges”. Founded by CRUK (Cancer ...
ESMO Study Confirms Precision Oncology Remains Largely Inaccessible to European Cancer Patients
As a European umbrella organisation, DiCE is vocal in addressing the disparities associated with cancer patients’ access to precision medicin...
Primary and Updated Analyses for DESTINY-Gastric02 Study: Trastuzumab Deruxtecan Continues to Demonstrate Benefit in Metastatic Gastric and Gastro-oesophageal Cancer
Human Epidermal Growth receptor 2 (HER2) is a protein involved in normal cell growth, found in small amounts in almost all human cells, including s...
Member Update from Turkey
The devastating earthquakes that struck southern Türkiye and northern Syria on 6 February have destroyed homes, hospitals, and roads.
...
DiCE Supports Act4Biosimilars to Increase Patient Access to Biologic Medicines
On 30 January, the Act4Biosimilars initiative hosted a virtual meeting with key stakeholders from across the healthcare space to discuss the Action...
16 February is World Cholangiocarcinoma Day
DiCE is proud to support GCCA’s international effort to raise much-needed awareness of CCA, devastating cancer that occurs in the bile ducts in o...
Raising Awareness for Rare Cancers – Anal Cancer Awareness Day March 21
Anal cancer is a rare cancer on the rise. In the EU 9.249 men and women were newly diagnosed with this cancer, in 2020
...
March 22 is Lynch Syndrome Awareness Day
Lynch Syndrome is the most common inherited cancer syndrome in the world, with an estimation of 1 in 370 people carrying the genetic mutation.
...
DiCE Materials Accessible in European Languages
Digestive Cancers Europe Makes Materials Accessible in European Languages
...